Molecular Characteristics of Clostridium perfringens TpeL Toxin and Consequences of Mono-O-GlcNAcylation of Ras in Living Cells*

Background: TpeL is a member of the family of clostridial glucosylating toxins, produced by Clostridium perfringens. Results: TpeL enters target cells by self-mediated entry and mono-glycosylates Ras proteins at Thr-35. Conclusion: TpeL inhibits Ras signaling and induces apoptosis in target cells. Significance: TpeL is a new glucosylating toxin produced by C. perfringens. TpeL is a member of the family of clostridial glucosylating toxins produced by Clostridium perfringens type A, B, and C strains. In contrast to other members of this toxin family, it lacks a C-terminal polypeptide repeat domain, which is suggested to be involved in target cell binding. It was shown that the glucosyltransferase domain of TpeL modifies Ras in vitro by mono-O-glucosylation or mono-O-GlcNAcylation (Nagahama, M., Ohkubo, A., Oda, M., Kobayashi, K., Amimoto, K., Miyamoto, K., and Sakurai, J. (2011) Infect. Immun. 79, 905–910). Here we show that TpeL preferably utilizes UDP-N-acetylglucosamine (UDP-GlcNAc) as a sugar donor. Change of alanine 383 of TpeL to isoleucine turns the sugar donor preference from UDP-GlcNAc to UDP-glucose. In contrast to previous studies, we show that Rac is a poor substrate in vitro and in vivo and requires 1–2 magnitudes higher toxin concentrations for modification by TpeL. The toxin is autoproteolytically processed in the presence of inositol hexakisphosphate (InsP6) by an intrinsic cysteine protease domain, located next to the glucosyltransferase domain. A C-terminally extended TpeL full-length variant (TpeL1–1779) induces apoptosis in HeLa cells (most likely by mono-O-GlcNAcylation of Ras), and inhibits Ras signaling including Ras-Raf interaction and ERK activation. In addition, TpeL blocks Ras signaling in rat pheochromocytoma PC12 cells. TpeL is a glucosylating toxin, which modifies Ras and induces apoptosis in target cells without having a typical C-terminal polypeptide repeat domain.

[1]  I. Just,et al.  Functional implications of lethal toxin-catalysed glucosylation of (H/K/N)Ras and Rac1 in Clostridium sordellii-associated disease. , 2011, European journal of cell biology.

[2]  K. Aktories,et al.  Inositol Hexakisphosphate-dependent Processing of Clostridium sordellii Lethal Toxin and Clostridium novyi α-Toxin* , 2011, The Journal of Biological Chemistry.

[3]  R. Benz,et al.  Structural determinants for membrane insertion, pore formation and translocation of Clostridium difficile toxin B , 2011, Molecular microbiology.

[4]  K. Miyamoto,et al.  Clostridium perfringens TpeL Glycosylates the Rac and Ras Subfamily Proteins , 2010, Infection and Immunity.

[5]  Karla J. F. Satchell,et al.  Inositol Hexakisphosphate-Induced Autoprocessing of Large Bacterial Protein Toxins , 2010, PLoS pathogens.

[6]  Constantinos Zamboglou,et al.  Clostridial Glucosylating Toxins Enter Cells via Clathrin-Mediated Endocytosis , 2010, PloS one.

[7]  K. Aktories,et al.  Clostridium perfringens, Clostridium difficile, and Other Clostridium Species , 2010 .

[8]  H. Genth,et al.  Distinct kinetics of (H/K/N)Ras glucosylation and Rac1 glucosylation catalysed by Clostridium sordellii lethal toxin , 2009, FEBS letters.

[9]  I. Just,et al.  Killing of rat basophilic leukemia cells by lethal toxin from Clostridium sordellii: critical role of phosphatidylinositide 3'-OH kinase/Akt signaling. , 2009, Biochemistry.

[10]  Boping Zhou,et al.  BMC Microbiology BioMed Central Methodology article Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium , 2008 .

[11]  Robert A. Weinberg,et al.  Ras oncogenes: split personalities , 2008, Nature Reviews Molecular Cell Biology.

[12]  K. Aktories,et al.  Structure and mode of action of clostridial glucosylating toxins: the ABCD model. , 2008, Trends in microbiology.

[13]  Klaus Aktories,et al.  Auto-catalytic Cleavage of Clostridium difficile Toxins A and B Depends on Cysteine Protease Activity* , 2007, Journal of Biological Chemistry.

[14]  M. Shimizu,et al.  A novel toxin homologous to large clostridial cytotoxins found in culture supernatant of Clostridium perfringens type C. , 2007, Microbiology.

[15]  K. Aktories,et al.  Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function. , 2007, Glycobiology.

[16]  S. Tenzer,et al.  Autocatalytic cleavage of Clostridium difficile toxin B , 2007, Nature.

[17]  M. Palcic,et al.  Carbohydrate recognition by Clostridium difficile toxin A , 2006, Nature Structural &Molecular Biology.

[18]  G. Schulz,et al.  Change of the Donor Substrate Specificity of Clostridium difficile Toxin B by Site-directed Mutagenesis* , 2005, Journal of Biological Chemistry.

[19]  G. Schulz,et al.  Structural basis for the function of Clostridium difficile toxin B. , 2005, Journal of molecular biology.

[20]  J. Ballard,et al.  Clostridium difficile Toxins: Mechanism of Action and Role in Disease , 2005, Clinical Microbiology Reviews.

[21]  I. Just,et al.  Large clostridial cytotoxins. , 2004, Reviews of physiology, biochemistry and pharmacology.

[22]  J. G. Smedley,et al.  The enteric toxins of Clostridium perfringens. , 2004, Reviews of physiology, biochemistry and pharmacology.

[23]  K. Aktories,et al.  Cellular Uptake of Clostridium difficile Toxin B , 2003, Journal of Biological Chemistry.

[24]  P. Lazarovici,et al.  Signaling Pathways for PC12 Cell Differentiation: Making the Right Connections , 2002, Science.

[25]  L. Petit,et al.  Clostridium perfringens: toxinotype and genotype. , 1999, Trends in microbiology.

[26]  S. Munro,et al.  A Common Motif of Eukaryotic Glycosyltransferases Is Essential for the Enzyme Activity of Large Clostridial Cytotoxins* , 1998, The Journal of Biological Chemistry.

[27]  J. Rood.  Virulence genes of Clostridium perfringens. , 1998, Annual review of microbiology.

[28]  K. Aktories,et al.  Localization of the Glucosyltransferase Activity of Clostridium difficile Toxin B to the N-terminal Part of the Holotoxin* , 1997, The Journal of Biological Chemistry.

[29]  B. McClane,et al.  The clostridia: molecular biology and pathogenesis , 1997 .

[30]  D. Stevens.  Necrotizing Clostridial Soft Tissue Infections , 1997 .

[31]  M. Wilm,et al.  Clostridium novyi α-Toxin-catalyzed Incorporation of GlcNAc into Rho Subfamily Proteins* , 1996, The Journal of Biological Chemistry.

[32]  D. Cussac,et al.  Ras, Rap, and Rac Small GTP-binding Proteins Are Targets for Clostridium sordellii Lethal Toxin Glucosylation (*) , 1996, The Journal of Biological Chemistry.

[33]  K. Aktories,et al.  Inactivation of Ras by Clostridium sordellii Lethal Toxin-catalyzed Glucosylation (*) , 1996, The Journal of Biological Chemistry.

[34]  M. Wilm,et al.  The Enterotoxin from Clostridium difficile (ToxA) Monoglucosylates the Rho Proteins(*) , 1995, The Journal of Biological Chemistry.

[35]  M. Mann,et al.  Glucosylation of Rho proteins by Clostridium difficile toxin B , 1995, Nature.

[36]  S. Cole,et al.  Molecular genetics and pathogenesis of Clostridium perfringens , 1991, Microbiological reviews.

[37]  C. Hatheway,et al.  Toxigenic clostridia , 1990, Clinical Microbiology Reviews.

[38]  C. von Eichel-Streiber,et al.  Clostridium difficile toxin A carries a C-terminal repetitive structure homologous to the carbohydrate binding region of streptococcal glycosyltransferases. , 1990, Gene.